GEN Exclusives

More »

GEN Exclusives

More »

For full access to this article login to GEN Select now.

May 5, 2014

Cancer Vaccines in the Omics Era

New technologies and approaches are leading to new breakthroughs.

Cancer Vaccines in the Omics Era

Tumor-specific antigens released from dying tumor cells killed in an immunologically relevant manner are phagocytized by dendritic cells and presented to T cells, which become activated against a broader array of targets. [NIH Medical Arts]

  • Until a few decades ago, cancer was mostly viewed as a genetic condition in which a single mutated cell clone survived and gave rise ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

    • Do not put any letters or characters here if you are not a spy program.
    •  

Get GEN Select Access Now



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Ebola Vaccines

When do you think an Ebola vaccine will be available for the general public?